Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
about
Syntaxin 4 is required for acid sphingomyelinase activity and apoptotic functionInhibition of acid sphingomyelinase by tricyclic antidepressants and analogonsEvolving concepts in cancer therapy through targeting sphingolipid metabolismLipid raft: A floating island of death or survivalInvolvement of raft aggregates enriched in Fas/CD95 death-inducing signaling complex in the antileukemic action of edelfosine in Jurkat cellsMembrane Transition Temperature Determines Cisplatin ResponsePreparation of a functional fluorescent human Fas ligand extracellular domain derivative using a three-dimensional structure guided site-specific fluorochrome conjugationNeutral sphingomyelinase 2 modulates cytotoxic effects of protopanaxadiol on different human cancer cells.Sphingolipids are involved in N-methyl-N'-nitro-N-nitrosoguanidine-induced epidermal growth factor receptor clustering.Re-configuration of sphingolipid metabolism by oncogenic transformation.Endothelial membrane remodeling is obligate for anti-angiogenic radiosensitization during tumor radiosurgery.Site-specific chemical conjugation of human Fas ligand extracellular domain using trans-cyclooctene - methyltetrazine reactionsEvaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cellsNanocarriers for delivery of platinum anticancer drugs.Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer RiskSynergistic induction of cell death in liver tumor cells by TRAIL and chemotherapeutic drugs via the BH3-only proteins Bim and BidGlioma cell death induced by irradiation or alkylating agent chemotherapy is independent of the intrinsic ceramide pathway.HIF-1α depletion results in SP1-mediated cell cycle disruption and alters the cellular response to chemotherapeutic drugs.Differential activation of acid sphingomyelinase and ceramide release determines invasiveness of Neisseria meningitidis into brain endothelial cells.Ceramide-rich platforms in transmembrane signaling.Modulation of Acid Sphingomyelinase in Melanoma Reprogrammes the Tumour Immune MicroenvironmentRecent advances in the immunobiology of ceramide.Physiological and pathophysiological aspects of ceramide.Targeting ceramide synthase 6-dependent metastasis-prone phenotype in lung cancer cells.Remodeling of cellular cytoskeleton by the acid sphingomyelinase/ceramide pathwayST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases.Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cellsFormation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes.Importance of the difference in surface pressures of the cell membrane in doxorubicin resistant cells that do not express Pgp and ABCG2.Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology.Ceramide in bacterial infections and cystic fibrosis.Essential role for acid sphingomyelinase-inhibited autophagy in melanoma response to cisplatin.Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.Sphingolipid Organization in the Plasma Membrane and the Mechanisms That Influence ItCeramide signaling in mammalian epidermis.The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin.Low dosages: new chemotherapeutic weapons on the battlefield of immune-related disease.
P2860
Q24303872-F69AF72D-D63A-4642-B051-535ED67EC59EQ26852322-651D75AD-E567-43C6-AD7F-87C4EB2CEAA9Q26863646-5411BA39-7A34-497B-AA38-C0E29C6C7881Q26998351-93F1440D-BB7F-42C5-8918-1FD77690EDFFQ28475228-A0405801-B717-4FB2-AFCD-2A265F65D9D0Q28550413-5532FAB0-D9ED-43B3-BFB7-FC4A8F15B9D1Q28831051-AD6D95C0-2F7F-4074-9CB2-691CAA68C53BQ31124060-2B60D9A8-9E8F-4ED7-BAFF-1D80745C82A1Q33213340-9EEEF3D0-7DD3-432E-A8C6-CCC76F03AF58Q33649823-A46B0B7E-8A1A-4A5E-8CD3-8A16D9CBB421Q33680346-C72D85DD-EFD7-4FE5-B5AD-E5CC94E59A6CQ33868706-D1D96659-2379-4082-A148-872F41656B92Q34068899-60477FFC-9AB0-458C-B924-CC812DF7D571Q34338695-B946523F-8D46-406B-BE72-A9F37DFA3CF1Q34494043-F6CB7AD0-E2CF-4DAB-95D1-3BD77C1439C9Q34561806-FA695DF3-B472-4AA7-93AD-A2005C75CFA5Q34718233-6AB42F5A-8627-4CC7-9543-C9460EC6DC4AQ35051166-7A45B1E9-61A1-4828-A1D2-B90F183F0F30Q35191042-EE1363B1-22BA-4AD5-847E-72E7CD23F82AQ35633883-E3909ABB-43CB-4F4D-B2CA-B4EDC2E478DEQ35697896-F679BBA7-E464-46C8-87D1-5740498663A0Q35916828-B9EAA72D-2BC7-439A-B9E7-8FBFA686457CQ36341274-03AD6B44-CBED-4F30-9D81-636344F3544FQ36430767-C5037E14-0BF1-4DAB-9764-0DB95F63563DQ36562936-F1E9AFEA-125D-45CE-8435-93D8A8C8EB80Q36798320-81B767A1-C1B1-4B9A-BBBF-7FDE0F35DD71Q36879383-5F6FB661-B143-4E97-80B1-72B3F41C8648Q36985163-E4787284-E5F0-48F1-8F45-202A516495D9Q36995176-0AC77B4B-0ECB-4709-A817-42C4D6FB9137Q37054441-475F497C-283C-4DFB-8634-91ED1E0D8A00Q37067277-DCCC04AD-7C5A-4655-B960-32C8A4449DBEQ37139330-D014DDE7-D03B-4033-A079-ABCFEC9EA67FQ37265527-ADDC31CE-AE13-4055-8F5D-FB13A8C2C83EQ37265533-4DAA8EE8-14D7-4BCC-9626-E1F8B8F2B715Q37295253-8633A309-9A7B-409E-83B6-BEBC5467407EQ37398338-02AA778A-4549-4887-B51F-97C2FD095184Q37574812-911BCC24-7853-43C5-B524-3ABC62B61969Q37619251-6EDDCB4A-75B3-4647-BF52-F1CC86AD7328Q37693895-F458EE8B-5A06-4691-B0C8-E4FCFD62E21EQ37728232-759E8EB2-C108-40FD-8288-6F3089702D61
P2860
Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cisplatin-induced CD95 redistr ...... HT29 human colon cancer cells.
@en
type
label
Cisplatin-induced CD95 redistr ...... HT29 human colon cancer cells.
@en
prefLabel
Cisplatin-induced CD95 redistr ...... HT29 human colon cancer cells.
@en
P2093
P50
P1433
P1476
Cisplatin-induced CD95 redistr ...... HT29 human colon cancer cells
@en
P2093
Anne Athias
Arlette Hammann
Guy Laurent
Odile Sergent
Philippe Gambert
Sandrine Lacour
Solène Grazide
P304
P356
10.1158/0008-5472.CAN-03-2787
P407
P577
2004-05-01T00:00:00Z